During the past decade, Qualmedica Research, LLC conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 6 clinical trials were completed, i.e. on average, 19.4% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 6 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Qualmedica Research, LLC" #1 sponsor was "Eli Lilly and Company" with 14 trials, followed by "Pfizer" with 4 trials sponsored, "Shire" with 4 trials sponsored, "Société des Produits Nestlé (SPN)" with 4 trials sponsored and "Abbott Nutrition" with 4 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Qualmedica Research, LLC" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "Database Integrations, Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Instat Consulting, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Qualmedica Research, LLC" are "Alopecia Areata" (3 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials), "Atopic Dermatitis" (2 trials), "Crohn's Disease" (2 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "Qualmedica Research, LLC" in a lesser frequency.

Most popular intervention types in "Qualmedica Research, LLC" are "Drug" (28 trials), "Other" (9 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Tirzepatide" (3 trials), "Baricitinib" (2 trials), "Lasmiditan" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Qualmedica Research, LLC" are 38 trials for "All" genders.

Currently, there are NaN active trials in "Qualmedica Research, LLC". undefined are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Qualmedica Research, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Qualmedica Research, LLC, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 8 trials that are defined as “Not Applicable".